1. Epigenetic Determinants of Racial Disparity in Breast Cancer: Looking beyond Genetic Alterations
   Shriya Joshi et al, 2022, Cancers CrossRef
2. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study
   Serena Bertozzi et al, 2021, BMC Cancer CrossRef
3. Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
   Jesús Beltrán-García et al, 2019, Frontiers in Genetics CrossRef
4. Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response
   Sheng-Chao Wang et al, 2021, Cancers CrossRef
5. PITX1 plays essential functions in cancer
   Jingpu Zhao et al, 2023, Frontiers in Oncology CrossRef
6. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
   Cora Palanca-Ballester et al, 2021, Cancers CrossRef
7. Development of Novel Cancer Biomarkers for Diagnosis and Prognosis
   Kholood Abid Janjua et al, 2022, Cancer Biomarkers in Diagnosis and Therapeutics CrossRef
8. Cancer epigenetics in clinical practice
   Veronica Davalos et al, 2023, CA: A Cancer Journal for Clinicians CrossRef
9. Research progress and applications of epigenetic biomarkers in cancer
   Jianjun Gao et al, 2024, Frontiers in Pharmacology CrossRef
10. PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients
    Rudolf Napieralski et al, 2021, Breast Care CrossRef
11. Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy
    Manfred Schmitt et al, 2018, Breast Care CrossRef
12. Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
    Gabriele Schricker et al, 2018, Scientific Reports CrossRef